Company record
Fagron Compounding Services
0 FDA warning letters since 2023 and 6 recalls in the last 12 months.
Get an email the day FDA posts anything new about Fagron Compounding Services.
Recalls
| Reported | Class | Firm | Product and reason |
|---|---|---|---|
| Apr 15 | Class II | Fagron Compounding Services Drug |
Vancomycin HCI, 1.5 grams added to 250 mL, 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N. Wichita, KS 67226, NDC 71266-5085-01 Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port FDA notice D-0441-2026 |
| Apr 15 | Class II | Fagron Compounding Services Drug |
Vancomycin HCI, 1.25 grams added to 250 mL, 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N. Wichita, KS 67226, NDC 71266-5083-01 Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port FDA notice D-0440-2026 |
| Apr 15 | Class II | Fagron Compounding Services Drug |
norepinephrine Bitartrate, 32mg per 250mL 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N. Wichita, KS 67226, NDC 71266-5027-02 Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port FDA notice D-0439-2026 |
| Apr 15 | Class II | Fagron Compounding Services Drug |
norepinephrine Bitartrate,16mg per 250mL 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N. Wichita, KS 67226, NDC 71266-5026-02 Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port FDA notice D-0438-2026 |
| Apr 15 | Class II | Fagron Compounding Services Drug |
Vancomycin HCL, 1 gram added to 250 mL, 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N. Wichita, KS 67226, NDC 71266-5082-01 Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port FDA notice D-0442-2026 |
| Dec 17, 2025 | Class II | Fagron Compounding Services Drug |
Tropicamide 1%/Cyclopentolate 1%/Phenylephrine 2.5%/Ketorolac 0.5% Topical Ophthalmic Solution, 0.5mL Single-Use Syringe, For Topical Ophthalmic Use Only. Not for IV Use. Fagron Sterile Services, 8710 E 34th St N, Wichi… Incorrect Product Formulation FDA notice D-0221-2026 |